Bio News
-
Bio News | Breaking News | Industry News
Catalent Biologics Launches GPEx Lightning Cell Line Expression Technology
Designed to shorten drug substance development timelines by up to three months.07.22.21
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Marvel Biotechnology Begins cGMP Manufacturing of Lead Candidate
Enters manufacturing agreement with Ausun Pharma for lead asset MB-204.07.22.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Minaris and bluebird bio Enter Manufacturing Pact
The CDMO will be the commercial manufacturer in Europe for Skysona, bluebird bio’s gene therapy for CALD.07.22.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Samsung Biologics, Kineta Enter Development and Manufacturing Agreement
Samsung's San Francisco R&D center and South Korea headquarters to offer end-to-end CDMO service for anti-VISTA antibody immunotherapy.07.20.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Curtana and Catalent Enter Brain Cancer Drug Partnership
Sign development and manufacturing agreement for brain cancer drug CT-179.07.16.21
-
Bio News | Breaking News | Industry News | Promotions & Moves
Vibalogics Advances Growth with Leadership Hires
Pharma industry vet Roger Lias joins the CDMO as chief commercial officer.07.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.07.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Parenterals
Batavia Manufactures IAVI’s Lassa Fever Vax Candidate
Uses innovative 'scale-X' bioreactor to support Phase I clinical trials.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Ashfield Launches Cell & Gene Therapy Commercialization Network
EmerGENE is designed to support small and midsize biotechs with the commercialization of their discoveries.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Curia to Acquire US-based LakePharma
Expanding end-to-end R&D capabilities and scale for biologics.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine
After successful completion, Batavia will continue to scale-up and optimize the process for commercial scale.07.08.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Aragen Expands Discovery Research Agreement with Boehringer Ingelheim
Aims to accelerate the discovery pipeline of Boehringer Ingelheim.07.01.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Waters Corp Expands Collaboration with BTI
Intends to accelerate bioprocessing and bioinformatics research in Singapore.07.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm Invests $850M to Expand Biologics Capabilities
Investment in CDMO business to add development and manufacturing capacity in US and UK.07.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development
Catalent to Acquire RheinCell Therapeutics
Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate
Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Senti Bio Invests in Cell Therapy Manufacturing Facility
92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Designed for clinical manufacturing and initial commercial manufacturing of rAAV gene therapy products.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
